SNCA and Parkinson disease: This mechanism is similar to the one used by alpha-synuclein in Parkinson’s disease, where cytosolic alpha-synuclein oligomerization inhibits SNARE-mediated vesicle fusion in dopaminergic neurons (Garcia-Reitböck et al., 2010; DeWitt and Rhoades, 2013).